We are live on ! Find out more
ACER

Acer Therapeutics Inc
ACER

Delisted

ACER was delisted on the 8th of November, 2023.

Back to rankings

12 hedge funds and large institutions have $389K invested in Acer Therapeutics Inc in 2013 Q2 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
+12
Holders Change %
–
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$132K +$153K +1,046 New
SKK
2
Shepherd Kaplan Krochuk
Massachusetts
$94K +$108K +738 New
KCG
3
Knight Capital Group
$53K +$62.1K +425 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$21K +$24.7K +169 New
Goldman Sachs
5
Goldman Sachs
New York
$19K +$22.3K +153 New
Northern Trust
6
Northern Trust
Illinois
$17K +$19.7K +135 New
PGFC
7
Peapack-Gladstone Financial Corp
New Jersey
$15.3K +$17.5K +120 New
Barclays
8
Barclays
United Kingdom
$10K +$11.5K +79 New
Deutsche Bank
9
Deutsche Bank
Germany
$10K +$12K +82 New
U
10
UBS
Switzerland
$9K +$9.49K +65 New
California Public Employees Retirement System
11
California Public Employees Retirement System
California
$9K +$10.7K +73 New
MWP
12
MYCIO Wealth Partners
Pennsylvania
– +$438 +3 New

ACER Hedge Fund Activity: Q2 2013 in Review

12 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q2 2013, worth a combined $389K.

Buyers outnumbered sellers: 12 funds opened new ACER positions and 0 closed out — a net gain of 12 holders — while 0 added to existing stakes and 0 trimmed.

  • 12 institutional investors held Acer Therapeutics Inc (ACER) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $389K of Acer Therapeutics Inc stock for Q2 2013.
  • 12 funds opened new Acer Therapeutics Inc positions in Q2 2013 and 0 closed out, a net change of +12 holders.

Based on aggregated 13F filings for Q2 2013.